type here...

CATEGORIES

Breaking Research

LATEST

123Page 2 of 3

TRENDING

EDITORS CHOICE

CAR T-mRNA Therapy For Cardiac Fibrosis: A New Way Forward

William Haseltine, PhD -
This is a series on the advances in CAR T, a remarkable immunotherapy treatment dubbed a “living drug.” This new therapy genetically modifies a patient’s cells to fight cancer, but current research efforts hope to treat autoimmune diseases, organ damage and more.

Perhaps, A Braver New World

John Nosta -
The drip, drip, drip of innovation might just be a myth. Change commonly occurs as a punctuated reality that’s a function of converging events...

Teaming Up Two Biotech Winners to Fight Cancer: CRISPR and CAR T

William Haseltine, PhD -
Advances in CAR T, a remarkable immunotherapy treatment dubbed a “living drug.” This new therapy genetically modifies a patient’s cells to fight cancer, but current research efforts hope to treat autoimmune diseases, organ damage and more.

Were the Billions Invested in Alzheimer’s Research Worthwhile?

Gil Bashe, Medika Life Editor -
It may seem that the COVID-19 vaccines appeared almost suddenly, like rabbits pulled from a magician’s hat, but the invention of mRNA-based vaccines that...

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories